Related Experiment Videos

[Chemiluminescent immunoassay for insulin]

Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|September 1, 1991
PubMed

Insights

This study presents a solid-phase chemiluminescent immunoassay for detecting insulin using a novel antibody labeling method. The assay demonstrates high sensitivity and a wide linear range for accurate insulin quantification.

Area of Science:

  • Biochemistry
  • Immunology
  • Analytical Chemistry

Context:

  • Accurate insulin measurement is crucial for diabetes management and research.
  • Existing immunoassays may have limitations in sensitivity or dynamic range.
  • Development of sensitive and reliable diagnostic tools is an ongoing need.

Purpose:

  • To develop and validate a solid-phase chemiluminescent immunoassay for insulin detection.
  • To utilize N-(4-aminobutyl)-N-ethylisoluminol (ABE1) labeled antibodies for enhanced signal generation.
  • To establish the assay's performance characteristics, including linear range and limit of detection.

Summary:

  • A solid-phase chemiluminescent immunoassay for insulin was developed using N-(4-aminobutyl)-N-ethylisoluminol (ABE1) labeled antibodies and a double antibodies sandwich technique.
  • The chemiluminescent system employed was ABEI-CoCl2-H2O2, providing a sensitive detection method.
  • The assay achieved a linear range of 0.3-150 microU/tube with a high correlation coefficient (0.985) and an absolute limit of detection of 0.32 microU/tube.

Impact:

  • This assay offers a highly sensitive and reliable method for insulin quantification.
  • The developed immunoassay can aid in clinical diagnostics and pharmacokinetic studies.
  • The findings contribute to the advancement of chemiluminescent immunoassay technology for biomarker detection.

Related Concept Videos